Plaque-type Psoriasis Trial (9-11 Weeks)

People who have been diagnosed with plaque psoriasis for at least 6 months and are 18-70 years of age, may qualify to participate in this clinical trial. Individuals must have stable active plaque-type psoriasis (with no clinically significant flares during the 12 weeks before their first dose of medication). Those with mild, moderate or severe disease may be eligible.

Participants will receive investigational oral medication (active study drug). Study medication will be provided at no cost. Reimbursement for study-related expenses will be provided.

Study participation will last about 9-11 weeks and include about 8-10 visits to the study center.

Call the study center near you, or register now.

Learn more about
Psoriasis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CA

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more